ENZYCHEM LIFESCIENCES (183490)

KOSDAQ · 990 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

83.8B

Rev (2025)

67.8B

Op Inc (2025)

-14.3B

Net Inc (2025)

-18.1B

PBR

0.60

52W

0K~1K

ENZYCHEM LIFESCIENCES operates in the Pharmaceuticals sector.

Legal name: ENZYCHEM LIFESCIENCES CORPORATION

In fiscal year 2025, ENZYCHEM LIFESCIENCES (183490) reported revenue of 67.8 billion KRW, down 12.4% from 77.4 billion KRW a year earlier.

Operating profit was -14.3 billion KRW and net income was -18.1 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 83.8 billion KRW, with a P/B of 0.60.

These figures can be verified in the DART filing (receipt no. 20260324000019).

Year	Rev	Op Inc	Net Inc
2025	67.8B	-14.3B	-18.1B
2024	77.4B	-13.2B	-22.1B
2023	76.0B	-14.4B	-9.4B

4 applicable out of 8 items

Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)

Semi-Annual Report (2026.06)

Checks

4 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Disclaimer of opinion. [source]

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: Treasury stock filings in the last 3 years: 3 disposal(s), 1 cancellation(s).

Embezzlement & Litigation: 9 embezzlement/litigation filing(s) in the last 180 days. [source]

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 6 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
2026-08-14	Semi-Annual Report (2026.06)